comparemela.com
Home
Live Updates
Why This BeiGene Analyst Slashes Forecast By Almost 42% - Be
Why This BeiGene Analyst Slashes Forecast By Almost 42% - Be
Why This BeiGene Analyst Slashes Forecast By Almost 42% - BeiGene (NASDAQ:BGNE), AbbVie (NYSE:ABBV)
BeiGene Ltd (NASDAQ: BGNE) declined in early trading on Friday, maintaining its downward trajectory through the week amid weakness in Chinese stocks.
Related Keywords
China ,
Chinese ,
Rebecca Liang ,
Beigene Ltd ,
Beigene Analyst ,
Market Perform ,
Beigene Thesis ,